Fusion Antibodies plc (FAB.L) LSE

16.00

-1.5(-8.57%)

Updated at August 18 04:46PM

Currency In GBp

Valuation

Market Cap2.14M
Enterprise Value982,906
P/E Ratio-5.46
PEG Ratio-0.16
Price/Sales Ratio10.09
Price/Book Ratio8.39
Enterprise/Revenue9.87
Enterprise/EBITDA-11.78

Fiscal Year

Fiscal YearMarch 31, 2024
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-0.9
Operating Margin-0.93

Management Effectiveness

Return On Assets-1.06
Return On Equity-1.14

Income Statement

Revenue1.14M
Revenue/Share0.03
Gross Profit-265,000
EBITDA-2.07M
Net Income-2.23M
Diluted EPS-0.04

Balance Sheet

Total Cash439,000
Total Cash/Share0.01
Total Debt32,000
Total Debt/Equity0.03
Current Ratio3.25
Book Value Per Share0.02

Price History

52-Week Change370.59
52-Week High18.15
52-Week Low2.8
Moving Average 50 Days8.63
Moving Average 200 Days7.27

Statistics

Average Volume1.13M
Shares Outstanding113.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A